This Houston expert describes the main phases central to any innovation journey. Photo courtesy of Slalom

As a technologist, one thing I learned early in my career about the technology landscape is its constant improvements and I understood that companies who kept up with those changes remain successful and competitive. However, only companies mastering a disciplined innovation framework are truly able to harness the power of emerging tech to help them solve their most complex business challenges.

Innovative solutions come in all shapes and sizes, but not all of them should come to life. Specifically, when considering digital solutions, there are a few widely accepted innovation approaches in the product engineering field. This quick guide describes the main phases central to any innovation journey.

Feasibility Study

Ideating can be fun but executing a feasibility study will ground you on what will work and what may still be science fiction. The thought here is to spend two to four weeks doing research and talking to experts to answer a few key questions that will help you determine the feasibility of your idea or concept. Through the study, you will learn how to look at it from both a technology and a business perspective. More importantly, to answer the question 'Is it even possible to accomplish your goal with this technology?'

A subject matter expert (SME) will quickly tell you yes or no and why. If you find the technology is indeed suitable, then you will move on to evaluate the business feasibility. Does it make financial sense? Does it work within established business policies? Will there be a healthy Return On Investment (ROI) within an acceptable timeline? If you find positive responses to those questions, then you should feel confident to move on to a Proof of Concept (PoC) or even jump to a Minimum Viable Product (MVP). On the other hand, if either the technology is not feasible or the solution doesn't make business sense, then you've just saved yourself a lot of time, budget, and possibly headaches.

Proof of Concept

This phase is about testing the theory and proving the hypothesis, technically speaking. You'll need to go through a Proof of Concept if the technology solution you have in mind hasn't been tested in either a lab setting or in the field. Thinking outside of the box and innovating is all about trying new approaches and solving problems in a novel way, so you'll have to spend the time and budget ensuring it will work as expected. However, you must be very careful to not get carried away.

A proper PoC should take four to six weeks, max. It should help you quickly determine whether the technology will live up to its promise or if you need to pivot to another approach. Building a team with the right skillset is vital to this process because they are the ones evaluating the proposed solution and comparing it to the expected outcomes. Any signs of discord should empower the team to stop the project, saving further investment, and should help you decide if another approach is even possible. If all criteria has been met, then move on to the MVP stage.

Minimum Viable Product

At this point, you have confirmed the solution you imagined works and you are ready to unlock its potential. But you must start small. You must prioritize all the features you want this product to have and decide what the core functionality should be. This is important because if you choose too many features to start with, you may initially spend too much money and time and may even miss a window of business opportunity you may have lined up. Hence the name of the MVP, it is a product that employs the minimum time, money, and features while still being a viable product.

In summary, if you have an innovative idea for a technology solution, I recommend you first determine whether it's feasible, both technology and business wise, through a short and focused study. If feasible, then you can put that concept to the test through a PoC and determine its desirability. If this product is indeed desirable, then moving into building an MVP will help you understand its viability – and that is how you can successfully innovate while keeping risks at bay.


------

Alfredo Arvide is the director for the products and innovation practice at Slalom Consulting in Houston, where he helps clients solve their most complex business challenges by leveraging emerging technologies and applying innovative technology solutions.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.